{"gene":"SETD3","run_date":"2026-06-10T07:46:31","timeline":{"discoveries":[{"year":2018,"finding":"SETD3 is the physiological actin histidine methyltransferase that methylates β-actin at His73 (N3 of histidine 73). Structural studies reveal an extensive network of interactions that clamps the actin peptide onto the surface of SETD3 to orient His73 correctly within the catalytic pocket. His73 methylation reduces the nucleotide-exchange rate on actin monomers and modestly accelerates actin filament assembly. Quantitative proteomics showed actin His73 methylation is the only detectable physiological substrate of SETD3.","method":"In vitro methyltransferase assay, X-ray crystallography, quantitative proteomics, SETD3 knockout mice","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure, in vitro reconstitution, mutagenesis-level functional assays, and quantitative proteomics in knockout animals; replicated by independent lab (PMID:30526847)","pmids":["30626964"],"is_preprint":false},{"year":2018,"finding":"SETD3 is the actin-specific histidine N-methyltransferase that methylates β-actin at H73 in vertebrates and Drosophila. Knockout of SETD3 in human HAP1 cells and Drosophila abolished H73 methylation. SETD3-deficient HAP1 cells show less cellular F-actin and an increased glycolytic phenotype.","method":"CRISPR/Cas9 knockout in HAP1 cells and Drosophila, mass spectrometry, in vitro methyltransferase assay with recombinant rat and human SETD3","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — independent replication of SETD3 as actin histidine methyltransferase using orthogonal methods (in vitro assay + KO in two model systems)","pmids":["30526847"],"is_preprint":false},{"year":2011,"finding":"Mouse SETD3 functions as a histone H3K4 and H3K36 methyltransferase with transcriptional activation activity; it is recruited to the myogenin gene promoter together with MyoD and activates transcription of muscle-related genes (myogenin, MCK, Myf6), promoting muscle cell differentiation. Knockdown of SETD3 retards muscle cell differentiation.","method":"Overexpression and shRNA knockdown in C2C12 cells, reporter assays, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — ChIP and functional differentiation assays, single lab; later work disputes histone H3 as physiological substrate but the muscle differentiation phenotype is supported","pmids":["21832073"],"is_preprint":false},{"year":2019,"finding":"SETD3 is required for enterovirus (EV) RNA replication independent of its methyltransferase activity. Cytosolic SETD3 specifically interacts with the viral 2A protease of multiple enteroviral species, and 2A mutants that retain protease activity but cannot interact with SETD3 are severely compromised in RNA replication. SETD3 is essential for in vivo EV replication and pathogenesis in mouse models.","method":"Genome-scale CRISPR screens, quantitative affinity purification-mass spectrometry (AP-MS), viral replication assays in SETD3-KO cells, in vivo mouse infection models","journal":"Nature microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — CRISPR screen + AP-MS + rescue experiments + in vivo mouse models; multiple orthogonal methods establishing SETD3–2A interaction and replication requirement","pmids":["31527793"],"is_preprint":false},{"year":2019,"finding":"Crystal structures of SAH-bound SETD3 in complex with unmodified or His73-methylated β-actin peptides show that recognition and methylation are highly sequence-specific and that both SETD3 and β-actin undergo pronounced conformational changes upon binding. The catalytic mechanism involves histidine methylation at N3.","method":"X-ray crystallography, biochemical enzyme activity assays, mutagenesis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures with functional validation by biochemical assays and mutagenesis in a single rigorous study","pmids":["30785395"],"is_preprint":false},{"year":2017,"finding":"SETD3 protein levels are cell cycle-regulated, peaking in S phase and lowest in M phase. The E3 ubiquitin ligase FBXW7β mediates SETD3 degradation via recognition of a phosphodegron (CPD1) that is phosphorylated by GSK3β. Mutations of the phosphorylated residues in CPD1 abolish FBXW7β–SETD3 interaction and prevent degradation.","method":"Co-immunoprecipitation, mutagenesis, GSK3β inhibition/depletion, cell cycle synchronization, xenograft mouse model","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, phospho-site mutagenesis, kinase inhibition, and in vivo xenograft; multiple orthogonal methods in one study","pmids":["28442573"],"is_preprint":false},{"year":2019,"finding":"SETD3 binds the N3-protonated form of actin His73 in a pre-reactive complex; after methyl transfer the product bears an N1-protonated, N3-methylated histidine. During catalysis the imidazole ring of His73 rotates ~105°, shifting the proton from N3 to N1 to deprotonate the target N3 atom prior to methyl transfer. Under conditions optimized for lysine deprotonation, SETD3 shows weak lysine methylation activity.","method":"X-ray crystallography (pre- and post-reactive complexes), in vitro methyltransferase assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural determination of pre- and post-reactive complexes with biochemical validation defines catalytic mechanism","pmids":["31388018"],"is_preprint":false},{"year":2016,"finding":"SETD3 binds and methylates the transcription factor FoxM1. Under basal conditions, SETD3 and FoxM1 are co-enriched on the VEGF promoter, and their dissociation under hypoxia correlates with increased VEGF expression.","method":"Proteomic interaction screen, Co-immunoprecipitation, methyltransferase assay, chromatin immunoprecipitation (ChIP)","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, direct methylation assay, and ChIP in single lab; FoxM1 methylation is distinct from the established actin substrate","pmids":["27845446"],"is_preprint":false},{"year":2019,"finding":"SETD3 is a positive regulator of DNA-damage-induced apoptosis; depletion from HCT-116 colon cancer cells significantly inhibits apoptosis after doxorubicin treatment. SETD3 binds p53 in cells upon doxorubicin treatment and its catalytic activity is required for p53 recruitment to target gene promoters and p53 target gene activation.","method":"Co-immunoprecipitation, ChIP, siRNA knockdown, apoptosis assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP + ChIP + functional knockdown with defined apoptosis readout; single lab with multiple orthogonal methods","pmids":["30683849"],"is_preprint":false},{"year":2015,"finding":"SETD3 was identified as a PCNA-interacting protein; the interaction was validated by co-immunoprecipitation from human cell extracts and by interaction analysis using recombinant proteins.","method":"Bimolecular fluorescence complementation (BiFC) screen, co-immunoprecipitation, recombinant protein interaction assay","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — BiFC screen validated by reciprocal Co-IP and recombinant protein assay; single lab","pmids":["26030842"],"is_preprint":false},{"year":2020,"finding":"SETD3 can methylate methionine in the context of an actin peptide in which His73 is substituted with methionine, generating S-methylmethionine. The 1.9 Å crystal structure reveals the thioether side chain is packed by aromatic rings of Tyr312 and Trp273 and the hydrocarbon side chain of Ile310 in the active site.","method":"X-ray crystallography (1.9 Å), in vitro methyltransferase assay, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure combined with biochemical assay and mutagenesis; single lab but rigorous structural and enzymatic data","pmids":["32503840"],"is_preprint":false},{"year":2020,"finding":"Active-site engineering (N255F + W273A double substitution) of SETD3 switches its target specificity from histidine to lysine methylation, achieving a 13-fold preference for lysine. X-ray crystallography shows that the target N3 atom of histidine and the terminal ε-amino nitrogen of lysine occupy the same active-site position.","method":"Active-site mutagenesis, in vitro methyltransferase assays (kcat/Km measurements), X-ray crystallography","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution with engineered variants, kinetic measurements, and crystal structure in one rigorous study","pmids":["31911441"],"is_preprint":false},{"year":2024,"finding":"SETD3 is localized on the outer mitochondrial membrane and is a mechanosensitive enzyme regulated by extracellular matrix stiffness. SETD3 directly methylates actin at His73, enhances F-actin polymerization around mitochondria, and is required for oxidative phosphorylation and mitochondrial complex I assembly and function. Loss of SETD3 leads to diminished F-actin around mitochondria and decreased mitochondrial branch length, branch number, and movement.","method":"Live-cell imaging, fractionation/localization assays, SETD3 loss-of-function with mitochondrial functional readouts (OXPHOS, complex I assembly), ECM stiffness modulation","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization tied to functional consequence, loss-of-function with multiple mitochondrial readouts; single lab with multiple orthogonal methods","pmids":["38896010"],"is_preprint":false},{"year":2022,"finding":"USP27, a deubiquitinase, specifically interacts with SETD3, negatively regulates its ubiquitination, and enhances its protein stability, thereby promoting hepatocellular carcinoma cell proliferation.","method":"Co-immunoprecipitation, ubiquitination assays, USP27 knockdown with SETD3 protein level measurement","journal":"Cellular and molecular life sciences","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus ubiquitination assay plus functional knockdown; single lab","pmids":["35018513"],"is_preprint":false},{"year":2024,"finding":"SETD3 methylates MCM7 at histidine-459 (H459me), which is required for CDT1-mediated chromatin loading of the MCM complex and replication origin firing. CDK2 phosphorylates SETD3 at Serine-21 during G1/S phase, which is required for DNA replication and cell cycle progression.","method":"Nascent-strand sequencing (NS-seq), biochemical co-immunoprecipitation, SETD3 enzymatic activity assays, H459 mutagenesis, CDK2 phosphorylation assays","journal":"Science China. Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (NS-seq, Co-IP, mutagenesis, phosphorylation assays) in single lab establishing new substrate and PTM","pmids":["39455502"],"is_preprint":false},{"year":2024,"finding":"SETD3 interacts with hnRNPK and collaboratively regulates pre-mRNA exon skipping. Together they regulate retention of exon 7 skipping in FNIP1, promoting FNIP1-mediated nuclear translocation of TFEB and subsequent induction of lysosomal and mitochondrial biogenesis.","method":"In situ proximity labeling/mass spectrometry, genome-wide RNA-seq, Co-immunoprecipitation, loss-of-function experiments","journal":"Cell insight","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity labeling + RNA-seq + Co-IP + functional rescue; single lab with multiple orthogonal methods","pmids":["39391005"],"is_preprint":false},{"year":2024,"finding":"NUDT16-mediated dePARylation stabilizes SETD3 by reversing PARP1-mediated ADP-ribosylation. The E3 ligase CHFR recognizes PARylated SETD3 for degradation. SETD3 associates with BRCA2 and promotes its recruitment to stalled replication forks and DNA double-strand break sites.","method":"Co-immunoprecipitation, PARylation/dePARylation assays, SETD3 depletion with replication stress readouts, cell irradiation sensitivity assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, PARylation assays, and functional depletion experiments; single lab","pmids":["38272222"],"is_preprint":false},{"year":2025,"finding":"SETD3 dimethylates CHD1 at lysine 209 (K209). This dimethylation enhances CHD1 protein stability by reducing its ubiquitination. SETD3-mediated CHD1 methylation enhances H3K4me3 marks and promotes transcriptional activation of TNF-NFκB pathway genes.","method":"In vitro methyltransferase assay, Co-immunoprecipitation, ubiquitination assays, ChIP, gene expression analysis","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro methyltransferase assay for new substrate plus functional ubiquitination and ChIP assays; single lab","pmids":["41045985"],"is_preprint":false},{"year":2025,"finding":"SETD3 interacts with α-centractin (ACTR1A), a key dynactin subunit, and methylates it in vitro. Fluorography of SETD3-KO cell lysates revealed at least five novel SETD3-dependent methylated proteins beyond β-actin.","method":"TurboID proximity labeling, mass spectrometry, CRISPR/Cas9 KO in three cell lines, radiochemical methyltransferase assay, fluorography","journal":"PeerJ","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — proximity labeling + in vitro assay; interaction and methylation shown in vitro but cellular substrate validation is incomplete; single lab","pmids":["41142317"],"is_preprint":false},{"year":2021,"finding":"SETD3 depletion in neurons leads to decreased actin polymerization (F-actin), reduced cellular ATP, diminished mitochondrial membrane potential, and increased ROS production, resulting in mitochondrial dysfunction and neuronal death following oxygen-glucose deprivation. PTEN upregulation after ischemia causes SETD3 downregulation, and inhibiting PTEN protects neurons through restoration of SETD3 and actin polymerization.","method":"siRNA knockdown, OGD/R model, mitochondrial function assays (ATP, membrane potential, ROS), actin polymerization assay, in vivo cerebral I/R rat model","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — loss-of-function with multiple mechanistic readouts linking SETD3–actin polymerization–mitochondrial function; single lab","pmids":["34218417"],"is_preprint":false},{"year":2019,"finding":"SETD3-deficient female mice show severe reduction in litter sizes due to primary maternal dystocia; depletion of SETD3 impairs signal-induced contraction in primary human uterine smooth muscle cells. Complete loss of actin His73 methylation was confirmed in multiple tissues of SETD3-null mice.","method":"SETD3 knockout mice, uterine smooth muscle contraction assays, SETD3 siRNA knockdown in primary human cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — defined phenotype with cellular mechanism (smooth muscle contraction) in KO mice and human primary cells; multiple tissues tested","pmids":["30626964"],"is_preprint":false},{"year":2025,"finding":"SETD3 interacts with BRD2 in the nucleus of mouse ESCs, and this interaction depends on the RSB domain of SETD3. Loss of SETD3 leads to reduced BRD2 recruitment to chromatin and transcriptional changes; the interaction was confirmed by co-immunoprecipitation, domain deletion analysis, and proximity ligation assays.","method":"Mass spectrometry (nuclear pull-down), Co-immunoprecipitation, domain deletion analysis, proximity ligation assay (PLA)","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — reciprocal Co-IP and PLA with domain mapping and functional chromatin consequence; single lab","pmids":["40944926"],"is_preprint":false},{"year":2024,"finding":"In mouse ESCs, SETD3 interacts with β-catenin (proximity ligation assay), and loss of SETD3 reduces nuclear β-catenin levels (without changing total protein or mRNA), decreasing canonical Wnt transcriptional activity and causing endoderm differentiation defects that can be rescued by re-expressing SETD3 or activating canonical Wnt signaling.","method":"Proximity ligation assay (PLA), time-course RNA-seq, nuclear fractionation, Wnt reporter assay, SETD3 rescue experiments","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — PLA + fractionation + reporter assay + rescue; single lab with multiple orthogonal methods","pmids":["38334393"],"is_preprint":false},{"year":2025,"finding":"SETD3 promotes H3K4 methylation at the NLRP3 transcription start site in hippocampal microglia, activating the NLRP3-Caspase-1-IL-1β signaling pathway and enhancing neuroinflammation after surgery.","method":"SETD3 knockdown via lentiviral injection, ChIP for H3K4me3 at NLRP3 promoter, neuroinflammation cytokine assays, behavioral tests","journal":"Experimental neurology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP-level ChIP with knockdown; single lab; histone methylation as direct substrate of SETD3 is disputed by other literature","pmids":["41175962"],"is_preprint":false},{"year":2023,"finding":"The Trp79 binding pocket of SETD3 plays an important role in efficient His73 methylation catalysis; substitution of Trp79 in β-actin peptides with less bulky or hydrophilic residues reduces SETD3 catalytic activity, and molecular dynamics simulations show the pocket is shaped to accommodate the large hydrophobic Trp79.","method":"In vitro methyltransferase assay (MALDI-TOF MS), molecular dynamics simulations, synthetic peptide substitutions","journal":"Chembiochem","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic substrate mutagenesis supported by computational analysis defining a distal binding determinant for SETD3 catalysis","pmids":["37581408"],"is_preprint":false},{"year":2025,"finding":"The pathogenic G74S β-actin mutation (associated with BWCFF syndrome) disrupts SETD3-mediated His73 methylation; enzymatic assays confirm slower turnover of mutant actin peptides, and mass spectrometry reveals decreased His73 methylation in recombinant mutant β-actin and patient-derived fibroblasts.","method":"Enzymatic turnover assays, mass spectrometry (patient fibroblasts and recombinant protein), molecular docking","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic assays plus mass spectrometry in patient-derived material; single lab","pmids":["40490999"],"is_preprint":false}],"current_model":"SETD3 is a dual-localization SET-domain enzyme whose primary established function is as the actin histidine-N3 methyltransferase that methylates β-actin at His73, a modification that reduces nucleotide exchange on monomers, promotes filament assembly, and is required for smooth muscle contractility; SETD3 also methylates MCM7 at His459 to promote replication origin firing, CHD1 at Lys209 to stabilize it and activate NFκB target genes, and α-centractin in vitro; its protein stability is controlled by GSK3β-FBXW7β-mediated ubiquitin-proteasomal degradation and NUDT16-mediated dePARylation; and, independent of its methyltransferase activity, cytosolic SETD3 interacts with enteroviral 2A protease and is essential for enterovirus RNA replication."},"narrative":{"mechanistic_narrative":"SETD3 is a SET-domain methyltransferase whose principal physiological function is the histidine-N3 methylation of β-actin at His73, the only detectable physiological substrate identified by quantitative proteomics, a modification that reduces nucleotide exchange on actin monomers and accelerates filament assembly [PMID:30626964, PMID:30526847]. Crystal structures of SAH-bound SETD3 with unmodified and methylated β-actin peptides define a highly sequence-specific recognition mode in which both enzyme and substrate undergo pronounced conformational changes [PMID:30785395], and catalysis proceeds through a ~105° rotation of the His73 imidazole ring that shifts a proton from N3 to N1 to deprotonate the target nitrogen prior to methyl transfer [PMID:31388018]; distal substrate determinants including the actin Trp79 pocket govern catalytic efficiency [PMID:37581408]. This actin-methylation activity is physiologically required for smooth muscle contractility, with SETD3-null mice showing maternal dystocia and impaired uterine smooth muscle contraction [PMID:30626964], and disease relevance is underscored by the BWCFF-associated β-actin G74S mutation, which impairs His73 methylation in patient-derived fibroblasts and recombinant protein [PMID:40490999]. Beyond actin, SETD3 methylates additional substrates to control distinct programs: MCM7 at His459 to license replication origin firing [PMID:39455502], CHD1 at Lys209 to stabilize it and activate TNF-NFκB target genes [PMID:41045985], and α-centractin in vitro [PMID:41142317]. In a methyltransferase-independent role, cytosolic SETD3 binds the enteroviral 2A protease and is essential for enterovirus RNA replication and pathogenesis [PMID:31527793]. SETD3 abundance is tightly regulated by competing post-translational pathways, including GSK3β-primed FBXW7β-mediated proteasomal degradation [PMID:28442573] and PARP1/NUDT16-controlled (de)PARylation that gates CHFR-dependent turnover [PMID:38272222]. SETD3 also localizes to the outer mitochondrial membrane, where mechanosensitive actin methylation supports F-actin organization, complex I assembly, and oxidative phosphorylation [PMID:38896010].","teleology":[{"year":2011,"claim":"Established the first functional context for SETD3, linking it to muscle gene transcription and differentiation before its true substrate was known.","evidence":"Overexpression/knockdown, reporter and ChIP assays in C2C12 myoblasts","pmids":["21832073"],"confidence":"Medium","gaps":["Assigned histone H3K4/H3K36 as substrate, later disputed","Did not identify actin as the physiological target","Mechanism connecting SETD3 to myogenin promoter unresolved"]},{"year":2015,"claim":"Identified SETD3 as a PCNA-interacting protein, providing an early hint of a replication-associated role.","evidence":"BiFC screen with Co-IP and recombinant protein validation","pmids":["26030842"],"confidence":"Medium","gaps":["Functional consequence of PCNA binding not defined","No methylation activity linked to the interaction"]},{"year":2016,"claim":"Proposed FoxM1 as a SETD3 substrate regulating VEGF transcription, extending candidate non-histone targets.","evidence":"Proteomic screen, Co-IP, methyltransferase and ChIP assays","pmids":["27845446"],"confidence":"Medium","gaps":["Methylation site on FoxM1 not mapped","Distinct from later-established actin substrate","Single lab without orthogonal in vivo confirmation"]},{"year":2017,"claim":"Defined how SETD3 protein levels are controlled across the cell cycle, establishing a kinase-coupled degradation circuit.","evidence":"Co-IP, phosphodegron mutagenesis, GSK3β inhibition, cell synchronization, xenografts","pmids":["28442573"],"confidence":"High","gaps":["Did not connect SETD3 stability to a specific enzymatic output","Upstream signals controlling GSK3β-dependent phosphorylation unclear"]},{"year":2018,"claim":"Resolved the central question of SETD3's physiological function by identifying β-actin His73 as its sole detectable substrate and defining the structural basis of recognition.","evidence":"In vitro methyltransferase assays, X-ray crystallography, quantitative proteomics, KO mice and HAP1/Drosophila knockouts","pmids":["30626964","30526847"],"confidence":"High","gaps":["Did not fully resolve catalytic proton-shuttling mechanism","Cellular consequences of His73 methylation only partially mapped"]},{"year":2019,"claim":"Defined the catalytic chemistry of histidine N3 methylation through pre- and post-reactive structures and linked the enzyme to a physiological smooth-muscle phenotype.","evidence":"Crystallography of reaction intermediates, biochemistry, and KO mice/human uterine smooth muscle contraction assays","pmids":["31388018","30785395","30626964"],"confidence":"High","gaps":["Why His73 methylation is required for contractility at the molecular level incompletely defined"]},{"year":2019,"claim":"Uncovered a methyltransferase-independent function in which SETD3 is hijacked by enteroviruses as an essential host factor for RNA replication.","evidence":"Genome-scale CRISPR screens, AP-MS, rescue with interaction-deficient 2A mutants, in vivo mouse infection","pmids":["31527793"],"confidence":"High","gaps":["Molecular role of SETD3 in the viral replication complex undefined","Structural basis of 2A protease interaction unknown"]},{"year":2019,"claim":"Linked SETD3 catalytic activity to p53-dependent apoptosis, expanding its candidate transcriptional roles.","evidence":"Co-IP, ChIP, siRNA knockdown, apoptosis assays in HCT-116 cells","pmids":["30683849"],"confidence":"Medium","gaps":["Direct p53 methylation site not established","Single cell line, single lab"]},{"year":2020,"claim":"Mapped the active-site determinants of substrate selectivity, showing histidine versus lysine/methionine targeting is governed by specific pocket residues.","evidence":"Crystallography of methionine-containing and engineered variants, kinetics, mutagenesis","pmids":["32503840","31911441"],"confidence":"High","gaps":["Engineered specificity switches not observed in cellular substrates","Physiological relevance of weak alternative activities unclear"]},{"year":2022,"claim":"Added a stabilizing deubiquitinase to the SETD3 regulatory network, tying its abundance to cancer cell proliferation.","evidence":"Co-IP, ubiquitination assays, USP27 knockdown in hepatocellular carcinoma cells","pmids":["35018513"],"confidence":"Medium","gaps":["Whether USP27 acts directly on SETD3 ubiquitin chains not fully resolved","Link to specific methylation output undefined"]},{"year":2024,"claim":"Identified MCM7 His459 as a new SETD3 substrate controlling origin licensing and connected CDK2 phosphorylation of SETD3 to S-phase entry.","evidence":"NS-seq, Co-IP, H459 mutagenesis, CDK2 phosphorylation assays","pmids":["39455502"],"confidence":"Medium","gaps":["In vivo requirement of MCM7 methylation not tested in animals","Single lab"]},{"year":2024,"claim":"Placed SETD3-mediated actin methylation at the outer mitochondrial membrane as a mechanosensitive regulator of mitochondrial structure and bioenergetics.","evidence":"Live-cell imaging, fractionation, loss-of-function with OXPHOS/complex I readouts, ECM stiffness modulation","pmids":["38896010"],"confidence":"Medium","gaps":["How ECM stiffness is transduced to SETD3 activity unknown","Direct mitochondrial actin substrate pool not defined"]},{"year":2024,"claim":"Connected SETD3 to PARylation-dependent stability control and to a role in BRCA2 recruitment during replication stress and DNA damage.","evidence":"Co-IP, PARylation/dePARylation assays, depletion with replication-stress and irradiation-sensitivity readouts","pmids":["38272222"],"confidence":"Medium","gaps":["Whether SETD3 methylates a DNA-repair substrate unresolved","Mechanism of BRCA2 recruitment undefined"]},{"year":2024,"claim":"Implicated SETD3 in splicing regulation through hnRNPK, linking it to TFEB-driven lysosomal and mitochondrial biogenesis.","evidence":"Proximity labeling/MS, RNA-seq, Co-IP, loss-of-function on FNIP1 exon skipping","pmids":["39391005"],"confidence":"Medium","gaps":["Catalytic dependence of splicing function not established","Direct RNA contact by SETD3 unknown"]},{"year":2024,"claim":"Established SETD3 as a regulator of canonical Wnt signaling and endoderm differentiation in ESCs via β-catenin.","evidence":"PLA, nuclear fractionation, Wnt reporter, time-course RNA-seq, rescue experiments","pmids":["38334393"],"confidence":"Medium","gaps":["Whether β-catenin is methylated not shown","Mechanism stabilizing nuclear β-catenin undefined"]},{"year":2025,"claim":"Expanded the SETD3 substrate/interactor repertoire to CHD1, α-centractin, and BRD2, and tied actin methylation to a human β-actin disease mutation.","evidence":"In vitro methyltransferase and ubiquitination assays, ChIP, TurboID/MS, PLA, domain mapping, enzymatic turnover on patient-derived actin","pmids":["41045985","41142317","40944926","40490999"],"confidence":"Medium","gaps":["Cellular validation of several new substrates incomplete","Catalytic versus scaffold contributions to BRD2/centractin interactions unresolved"]},{"year":null,"claim":"It remains unresolved which non-actin substrates and interactions are catalytically dependent and physiologically significant, and how SETD3's nuclear, cytosolic, and mitochondrial pools are functionally partitioned.","evidence":"No single study reconciles the multiple proposed substrates and localizations","pmids":[],"confidence":"Low","gaps":["No unified model of substrate hierarchy beyond β-actin","Localization-specific activity regulation undefined","Catalytic requirement of viral and chromatin interactions only partly tested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,4,6,14,17,18]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,14,17,18]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[0,1,18]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14,21,22]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[12]}],"pathway":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,14,17]}],"complexes":[],"partners":["ACTB","MCM7","CHD1","ACTR1A","BRD2","HNRNPK","FBXW7","BRCA2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q86TU7","full_name":"Actin-histidine N-methyltransferase","aliases":["Protein-L-histidine N-tele-methyltransferase","SET domain-containing protein 3","hSETD3"],"length_aa":594,"mass_kda":67.3,"function":"Protein-histidine N-methyltransferase that specifically mediates 3-methylhistidine (tele-methylhistidine) methylation of actin at 'His-73' (PubMed:30526847, PubMed:30626964, PubMed:30785395, PubMed:31388018, PubMed:31993215). Histidine methylation of actin is required for smooth muscle contraction of the laboring uterus during delivery (PubMed:30626964). Does not have protein-lysine N-methyltransferase activity and probably only catalyzes histidine methylation of actin (PubMed:30626964, PubMed:30785395, PubMed:31388018)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q86TU7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SETD3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SETD3","total_profiled":1310},"omim":[{"mim_id":"620995","title":"SET DOMAIN-CONTAINING PROTEIN 4; SETD4","url":"https://www.omim.org/entry/620995"},{"mim_id":"615671","title":"SET DOMAIN-CONTAINING PROTEIN 3; SETD3","url":"https://www.omim.org/entry/615671"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SETD3"},"hgnc":{"alias_symbol":["FLJ23027"],"prev_symbol":["C14orf154"]},"alphafold":{"accession":"Q86TU7","domains":[{"cath_id":"3.90.1410.10","chopping":"74-324","consensus_level":"high","plddt":98.1375,"start":74,"end":324},{"cath_id":"3.90.1420.10","chopping":"335-501","consensus_level":"high","plddt":97.5117,"start":335,"end":501}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86TU7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86TU7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86TU7-F1-predicted_aligned_error_v6.png","plddt_mean":86.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SETD3","jax_strain_url":"https://www.jax.org/strain/search?query=SETD3"},"sequence":{"accession":"Q86TU7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86TU7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86TU7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86TU7"}},"corpus_meta":[{"pmid":"30626964","id":"PMC_30626964","title":"SETD3 is an actin histidine methyltransferase that prevents primary dystocia.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/30626964","citation_count":135,"is_preprint":false},{"pmid":"30526847","id":"PMC_30526847","title":"SETD3 protein is the actin-specific histidine N-methyltransferase.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30526847","citation_count":98,"is_preprint":false},{"pmid":"21832073","id":"PMC_21832073","title":"Histone methyltransferase SETD3 regulates muscle differentiation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21832073","citation_count":78,"is_preprint":false},{"pmid":"31527793","id":"PMC_31527793","title":"Enterovirus pathogenesis requires the host methyltransferase SETD3.","date":"2019","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/31527793","citation_count":61,"is_preprint":false},{"pmid":"30785395","id":"PMC_30785395","title":"Structural insights into SETD3-mediated histidine methylation on β-actin.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30785395","citation_count":51,"is_preprint":false},{"pmid":"28442573","id":"PMC_28442573","title":"Cell cycle-dependent degradation of the methyltransferase SETD3 attenuates cell proliferation and liver tumorigenesis.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28442573","citation_count":46,"is_preprint":false},{"pmid":"21307598","id":"PMC_21307598","title":"Characterization of a novel histone H3K36 methyltransferase setd3 in zebrafish.","date":"2011","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21307598","citation_count":36,"is_preprint":false},{"pmid":"30683849","id":"PMC_30683849","title":"SETD3 is a positive regulator of DNA-damage-induced apoptosis.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30683849","citation_count":35,"is_preprint":false},{"pmid":"31388018","id":"PMC_31388018","title":"Structural basis for the target specificity of actin histidine methyltransferase SETD3.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31388018","citation_count":35,"is_preprint":false},{"pmid":"27845446","id":"PMC_27845446","title":"Chromatin associated SETD3 negatively regulates VEGF expression.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27845446","citation_count":34,"is_preprint":false},{"pmid":"30796205","id":"PMC_30796205","title":"MiR-15b and miR-322 inhibit SETD3 expression to repress muscle cell differentiation.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30796205","citation_count":32,"is_preprint":false},{"pmid":"23065515","id":"PMC_23065515","title":"The role of a newly identified SET domain-containing protein, SETD3, in oncogenesis.","date":"2012","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/23065515","citation_count":32,"is_preprint":false},{"pmid":"29950684","id":"PMC_29950684","title":"SETD3 negatively regulates VEGF expression during hypoxic pulmonary hypertension in rats.","date":"2018","source":"Hypertension research : official journal of the Japanese Society of Hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/29950684","citation_count":24,"is_preprint":false},{"pmid":"34218417","id":"PMC_34218417","title":"SETD3 Downregulation Mediates PTEN Upregulation-Induced Ischemic Neuronal Death Through Suppression of Actin Polymerization and Mitochondrial Function.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34218417","citation_count":21,"is_preprint":false},{"pmid":"26030842","id":"PMC_26030842","title":"A fluorescent bimolecular complementation screen reveals MAF1, RNF7 and SETD3 as PCNA-associated proteins in human cells.","date":"2015","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26030842","citation_count":21,"is_preprint":false},{"pmid":"35018513","id":"PMC_35018513","title":"Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35018513","citation_count":20,"is_preprint":false},{"pmid":"31654063","id":"PMC_31654063","title":"SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/31654063","citation_count":19,"is_preprint":false},{"pmid":"32278113","id":"PMC_32278113","title":"Characterization of a novel lncRNA (SETD3-OT) in turbot (Scophthalmus maximus L.).","date":"2020","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32278113","citation_count":17,"is_preprint":false},{"pmid":"32503840","id":"PMC_32503840","title":"Characterization of SETD3 methyltransferase-mediated protein methionine methylation.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32503840","citation_count":15,"is_preprint":false},{"pmid":"31911441","id":"PMC_31911441","title":"An engineered variant of SETD3 methyltransferase alters target specificity from histidine to lysine methylation.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31911441","citation_count":15,"is_preprint":false},{"pmid":"34032009","id":"PMC_34032009","title":"β-Actin Peptide-Based Inhibitors of Histidine Methyltransferase SETD3.","date":"2021","source":"ChemMedChem","url":"https://pubmed.ncbi.nlm.nih.gov/34032009","citation_count":14,"is_preprint":false},{"pmid":"34685411","id":"PMC_34685411","title":"The Structure, Activity, and Function of the SETD3 Protein Histidine Methyltransferase.","date":"2021","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34685411","citation_count":12,"is_preprint":false},{"pmid":"31235251","id":"PMC_31235251","title":"SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.","date":"2019","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/31235251","citation_count":12,"is_preprint":false},{"pmid":"35481649","id":"PMC_35481649","title":"Histidine methyltransferase SETD3 methylates structurally diverse histidine mimics in actin.","date":"2022","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/35481649","citation_count":12,"is_preprint":false},{"pmid":"32240818","id":"PMC_32240818","title":"Overexpression of CXCR5 in CD4+ T cells of SLE patients caused by excessive SETD3.","date":"2020","source":"Clinical immunology (Orlando, Fla.)","url":"https://pubmed.ncbi.nlm.nih.gov/32240818","citation_count":10,"is_preprint":false},{"pmid":"34861803","id":"PMC_34861803","title":"Circ_SETD3 regulates gefitinib sensitivity and tumor progression by miR-873-5p-dependent regulation of APPBP2 in non-small cell lung cancer.","date":"2021","source":"Journal of chemotherapy (Florence, Italy)","url":"https://pubmed.ncbi.nlm.nih.gov/34861803","citation_count":9,"is_preprint":false},{"pmid":"38896010","id":"PMC_38896010","title":"SETD3 is a mechanosensitive enzyme that methylates actin on His73 to regulate mitochondrial dynamics and function.","date":"2024","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38896010","citation_count":7,"is_preprint":false},{"pmid":"37581408","id":"PMC_37581408","title":"The Role of Trp79 in β-Actin on Histidine Methyltransferase SETD3 Catalysis.","date":"2023","source":"Chembiochem : a European journal of chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37581408","citation_count":7,"is_preprint":false},{"pmid":"34499935","id":"PMC_34499935","title":"Up-regulation of SETD3 may contribute to post-stroke depression in rat through negatively regulating VEGF expression.","date":"2021","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/34499935","citation_count":7,"is_preprint":false},{"pmid":"35550916","id":"PMC_35550916","title":"Structure-function conservation between the methyltransferases SETD3 and SETD6.","date":"2022","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/35550916","citation_count":6,"is_preprint":false},{"pmid":"35891342","id":"PMC_35891342","title":"Proteolytic Activities of Enterovirus 2A Do Not Depend on Its Interaction with SETD3.","date":"2022","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/35891342","citation_count":6,"is_preprint":false},{"pmid":"30067821","id":"PMC_30067821","title":"Phenotypic characterization of SETD3 knockout Drosophila.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30067821","citation_count":6,"is_preprint":false},{"pmid":"38334393","id":"PMC_38334393","title":"SETD3 regulates endoderm differentiation of mouse embryonic stem cells through canonical Wnt signaling pathway.","date":"2024","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/38334393","citation_count":5,"is_preprint":false},{"pmid":"38272222","id":"PMC_38272222","title":"The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38272222","citation_count":5,"is_preprint":false},{"pmid":"35912180","id":"PMC_35912180","title":"SETD3 Methyltransferase Regulates PLK1 Expression to Promote In Situ Hepatic Carcinogenesis.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35912180","citation_count":3,"is_preprint":false},{"pmid":"39391005","id":"PMC_39391005","title":"The methyltransferase SETD3 regulates mRNA alternative splicing through interacting with hnRNPK.","date":"2024","source":"Cell insight","url":"https://pubmed.ncbi.nlm.nih.gov/39391005","citation_count":3,"is_preprint":false},{"pmid":"39488591","id":"PMC_39488591","title":"Examining prestructured β-actin peptides as substrates of histidine methyltransferase SETD3.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39488591","citation_count":3,"is_preprint":false},{"pmid":"39299385","id":"PMC_39299385","title":"SETD3 functions beyond histidine methylation.","date":"2024","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39299385","citation_count":2,"is_preprint":false},{"pmid":"39455502","id":"PMC_39455502","title":"SETD3-mediated histidine methylation of MCM7 regulates DNA replication by facilitating chromatin loading of MCM.","date":"2024","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39455502","citation_count":2,"is_preprint":false},{"pmid":"40490999","id":"PMC_40490999","title":"Disruption of SETD3-mediated histidine-73 methylation by the BWCFF-associated β-actin G74S mutation.","date":"2025","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/40490999","citation_count":2,"is_preprint":false},{"pmid":"36520638","id":"PMC_36520638","title":"Structural and Energetic Origin of Different Product Specificities and Activities for SETD3 and Its Mutants on the Methylation of the β-Actin H73K Peptide: Insights from a QM/MM Study.","date":"2022","source":"Journal of chemical theory and computation","url":"https://pubmed.ncbi.nlm.nih.gov/36520638","citation_count":2,"is_preprint":false},{"pmid":"37269914","id":"PMC_37269914","title":"Zebrafish SETD3 mediated ubiquitination of phosphoprotein limits spring viremia of carp virus infection.","date":"2023","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37269914","citation_count":2,"is_preprint":false},{"pmid":"35419695","id":"PMC_35419695","title":"Computational Study of Methionine Methylation Process Catalyzed by SETD3.","date":"2022","source":"Interdisciplinary sciences, computational life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35419695","citation_count":2,"is_preprint":false},{"pmid":"36495785","id":"PMC_36495785","title":"A novel SETD3-ALK fusion in lung adenocarcinoma and sustained clinical response to crizotinib.","date":"2022","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/36495785","citation_count":2,"is_preprint":false},{"pmid":"41175962","id":"PMC_41175962","title":"Microglial hyperactivation and NLRP3 methylation mediated by SETD3 after anesthesia/surgery: Unraveling new mechanisms of perioperative neurocognitive disorders.","date":"2025","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/41175962","citation_count":1,"is_preprint":false},{"pmid":"41272740","id":"PMC_41272740","title":"SETD3 regulates Bcl-6 expression and Tfh differentiation in SLE CD4+ T cells by manipulating histone methylation and acetylation.","date":"2025","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/41272740","citation_count":1,"is_preprint":false},{"pmid":"41045985","id":"PMC_41045985","title":"The Actin Histidine methyltransferase SETD3 is a CHD1 lysine di-methyltransferase.","date":"2025","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/41045985","citation_count":0,"is_preprint":false},{"pmid":"41142317","id":"PMC_41142317","title":"Alpha-centractin is a novel substrate of SETD3 methyltransferase in vitro.","date":"2025","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/41142317","citation_count":0,"is_preprint":false},{"pmid":"40944926","id":"PMC_40944926","title":"SET domain containing 3 (SETD3) interacts with bromodomain-containing protein 2 (BRD2) and coordinates its chromatin association in mouse embryonic stem cells.","date":"2025","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/40944926","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25154,"output_tokens":6392,"usd":0.085671,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15219,"output_tokens":4650,"usd":0.096172,"stage2_stop_reason":"end_turn"},"total_usd":0.181843,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"SETD3 is the physiological actin histidine methyltransferase that methylates β-actin at His73 (N3 of histidine 73). Structural studies reveal an extensive network of interactions that clamps the actin peptide onto the surface of SETD3 to orient His73 correctly within the catalytic pocket. His73 methylation reduces the nucleotide-exchange rate on actin monomers and modestly accelerates actin filament assembly. Quantitative proteomics showed actin His73 methylation is the only detectable physiological substrate of SETD3.\",\n      \"method\": \"In vitro methyltransferase assay, X-ray crystallography, quantitative proteomics, SETD3 knockout mice\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure, in vitro reconstitution, mutagenesis-level functional assays, and quantitative proteomics in knockout animals; replicated by independent lab (PMID:30526847)\",\n      \"pmids\": [\"30626964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SETD3 is the actin-specific histidine N-methyltransferase that methylates β-actin at H73 in vertebrates and Drosophila. Knockout of SETD3 in human HAP1 cells and Drosophila abolished H73 methylation. SETD3-deficient HAP1 cells show less cellular F-actin and an increased glycolytic phenotype.\",\n      \"method\": \"CRISPR/Cas9 knockout in HAP1 cells and Drosophila, mass spectrometry, in vitro methyltransferase assay with recombinant rat and human SETD3\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — independent replication of SETD3 as actin histidine methyltransferase using orthogonal methods (in vitro assay + KO in two model systems)\",\n      \"pmids\": [\"30526847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mouse SETD3 functions as a histone H3K4 and H3K36 methyltransferase with transcriptional activation activity; it is recruited to the myogenin gene promoter together with MyoD and activates transcription of muscle-related genes (myogenin, MCK, Myf6), promoting muscle cell differentiation. Knockdown of SETD3 retards muscle cell differentiation.\",\n      \"method\": \"Overexpression and shRNA knockdown in C2C12 cells, reporter assays, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — ChIP and functional differentiation assays, single lab; later work disputes histone H3 as physiological substrate but the muscle differentiation phenotype is supported\",\n      \"pmids\": [\"21832073\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETD3 is required for enterovirus (EV) RNA replication independent of its methyltransferase activity. Cytosolic SETD3 specifically interacts with the viral 2A protease of multiple enteroviral species, and 2A mutants that retain protease activity but cannot interact with SETD3 are severely compromised in RNA replication. SETD3 is essential for in vivo EV replication and pathogenesis in mouse models.\",\n      \"method\": \"Genome-scale CRISPR screens, quantitative affinity purification-mass spectrometry (AP-MS), viral replication assays in SETD3-KO cells, in vivo mouse infection models\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — CRISPR screen + AP-MS + rescue experiments + in vivo mouse models; multiple orthogonal methods establishing SETD3–2A interaction and replication requirement\",\n      \"pmids\": [\"31527793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Crystal structures of SAH-bound SETD3 in complex with unmodified or His73-methylated β-actin peptides show that recognition and methylation are highly sequence-specific and that both SETD3 and β-actin undergo pronounced conformational changes upon binding. The catalytic mechanism involves histidine methylation at N3.\",\n      \"method\": \"X-ray crystallography, biochemical enzyme activity assays, mutagenesis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures with functional validation by biochemical assays and mutagenesis in a single rigorous study\",\n      \"pmids\": [\"30785395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SETD3 protein levels are cell cycle-regulated, peaking in S phase and lowest in M phase. The E3 ubiquitin ligase FBXW7β mediates SETD3 degradation via recognition of a phosphodegron (CPD1) that is phosphorylated by GSK3β. Mutations of the phosphorylated residues in CPD1 abolish FBXW7β–SETD3 interaction and prevent degradation.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis, GSK3β inhibition/depletion, cell cycle synchronization, xenograft mouse model\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, phospho-site mutagenesis, kinase inhibition, and in vivo xenograft; multiple orthogonal methods in one study\",\n      \"pmids\": [\"28442573\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETD3 binds the N3-protonated form of actin His73 in a pre-reactive complex; after methyl transfer the product bears an N1-protonated, N3-methylated histidine. During catalysis the imidazole ring of His73 rotates ~105°, shifting the proton from N3 to N1 to deprotonate the target N3 atom prior to methyl transfer. Under conditions optimized for lysine deprotonation, SETD3 shows weak lysine methylation activity.\",\n      \"method\": \"X-ray crystallography (pre- and post-reactive complexes), in vitro methyltransferase assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural determination of pre- and post-reactive complexes with biochemical validation defines catalytic mechanism\",\n      \"pmids\": [\"31388018\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SETD3 binds and methylates the transcription factor FoxM1. Under basal conditions, SETD3 and FoxM1 are co-enriched on the VEGF promoter, and their dissociation under hypoxia correlates with increased VEGF expression.\",\n      \"method\": \"Proteomic interaction screen, Co-immunoprecipitation, methyltransferase assay, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, direct methylation assay, and ChIP in single lab; FoxM1 methylation is distinct from the established actin substrate\",\n      \"pmids\": [\"27845446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETD3 is a positive regulator of DNA-damage-induced apoptosis; depletion from HCT-116 colon cancer cells significantly inhibits apoptosis after doxorubicin treatment. SETD3 binds p53 in cells upon doxorubicin treatment and its catalytic activity is required for p53 recruitment to target gene promoters and p53 target gene activation.\",\n      \"method\": \"Co-immunoprecipitation, ChIP, siRNA knockdown, apoptosis assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP + ChIP + functional knockdown with defined apoptosis readout; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30683849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SETD3 was identified as a PCNA-interacting protein; the interaction was validated by co-immunoprecipitation from human cell extracts and by interaction analysis using recombinant proteins.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC) screen, co-immunoprecipitation, recombinant protein interaction assay\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — BiFC screen validated by reciprocal Co-IP and recombinant protein assay; single lab\",\n      \"pmids\": [\"26030842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SETD3 can methylate methionine in the context of an actin peptide in which His73 is substituted with methionine, generating S-methylmethionine. The 1.9 Å crystal structure reveals the thioether side chain is packed by aromatic rings of Tyr312 and Trp273 and the hydrocarbon side chain of Ile310 in the active site.\",\n      \"method\": \"X-ray crystallography (1.9 Å), in vitro methyltransferase assay, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure combined with biochemical assay and mutagenesis; single lab but rigorous structural and enzymatic data\",\n      \"pmids\": [\"32503840\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Active-site engineering (N255F + W273A double substitution) of SETD3 switches its target specificity from histidine to lysine methylation, achieving a 13-fold preference for lysine. X-ray crystallography shows that the target N3 atom of histidine and the terminal ε-amino nitrogen of lysine occupy the same active-site position.\",\n      \"method\": \"Active-site mutagenesis, in vitro methyltransferase assays (kcat/Km measurements), X-ray crystallography\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution with engineered variants, kinetic measurements, and crystal structure in one rigorous study\",\n      \"pmids\": [\"31911441\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SETD3 is localized on the outer mitochondrial membrane and is a mechanosensitive enzyme regulated by extracellular matrix stiffness. SETD3 directly methylates actin at His73, enhances F-actin polymerization around mitochondria, and is required for oxidative phosphorylation and mitochondrial complex I assembly and function. Loss of SETD3 leads to diminished F-actin around mitochondria and decreased mitochondrial branch length, branch number, and movement.\",\n      \"method\": \"Live-cell imaging, fractionation/localization assays, SETD3 loss-of-function with mitochondrial functional readouts (OXPHOS, complex I assembly), ECM stiffness modulation\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization tied to functional consequence, loss-of-function with multiple mitochondrial readouts; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38896010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"USP27, a deubiquitinase, specifically interacts with SETD3, negatively regulates its ubiquitination, and enhances its protein stability, thereby promoting hepatocellular carcinoma cell proliferation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, USP27 knockdown with SETD3 protein level measurement\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus ubiquitination assay plus functional knockdown; single lab\",\n      \"pmids\": [\"35018513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SETD3 methylates MCM7 at histidine-459 (H459me), which is required for CDT1-mediated chromatin loading of the MCM complex and replication origin firing. CDK2 phosphorylates SETD3 at Serine-21 during G1/S phase, which is required for DNA replication and cell cycle progression.\",\n      \"method\": \"Nascent-strand sequencing (NS-seq), biochemical co-immunoprecipitation, SETD3 enzymatic activity assays, H459 mutagenesis, CDK2 phosphorylation assays\",\n      \"journal\": \"Science China. Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (NS-seq, Co-IP, mutagenesis, phosphorylation assays) in single lab establishing new substrate and PTM\",\n      \"pmids\": [\"39455502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"SETD3 interacts with hnRNPK and collaboratively regulates pre-mRNA exon skipping. Together they regulate retention of exon 7 skipping in FNIP1, promoting FNIP1-mediated nuclear translocation of TFEB and subsequent induction of lysosomal and mitochondrial biogenesis.\",\n      \"method\": \"In situ proximity labeling/mass spectrometry, genome-wide RNA-seq, Co-immunoprecipitation, loss-of-function experiments\",\n      \"journal\": \"Cell insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity labeling + RNA-seq + Co-IP + functional rescue; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"39391005\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NUDT16-mediated dePARylation stabilizes SETD3 by reversing PARP1-mediated ADP-ribosylation. The E3 ligase CHFR recognizes PARylated SETD3 for degradation. SETD3 associates with BRCA2 and promotes its recruitment to stalled replication forks and DNA double-strand break sites.\",\n      \"method\": \"Co-immunoprecipitation, PARylation/dePARylation assays, SETD3 depletion with replication stress readouts, cell irradiation sensitivity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, PARylation assays, and functional depletion experiments; single lab\",\n      \"pmids\": [\"38272222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETD3 dimethylates CHD1 at lysine 209 (K209). This dimethylation enhances CHD1 protein stability by reducing its ubiquitination. SETD3-mediated CHD1 methylation enhances H3K4me3 marks and promotes transcriptional activation of TNF-NFκB pathway genes.\",\n      \"method\": \"In vitro methyltransferase assay, Co-immunoprecipitation, ubiquitination assays, ChIP, gene expression analysis\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro methyltransferase assay for new substrate plus functional ubiquitination and ChIP assays; single lab\",\n      \"pmids\": [\"41045985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETD3 interacts with α-centractin (ACTR1A), a key dynactin subunit, and methylates it in vitro. Fluorography of SETD3-KO cell lysates revealed at least five novel SETD3-dependent methylated proteins beyond β-actin.\",\n      \"method\": \"TurboID proximity labeling, mass spectrometry, CRISPR/Cas9 KO in three cell lines, radiochemical methyltransferase assay, fluorography\",\n      \"journal\": \"PeerJ\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proximity labeling + in vitro assay; interaction and methylation shown in vitro but cellular substrate validation is incomplete; single lab\",\n      \"pmids\": [\"41142317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"SETD3 depletion in neurons leads to decreased actin polymerization (F-actin), reduced cellular ATP, diminished mitochondrial membrane potential, and increased ROS production, resulting in mitochondrial dysfunction and neuronal death following oxygen-glucose deprivation. PTEN upregulation after ischemia causes SETD3 downregulation, and inhibiting PTEN protects neurons through restoration of SETD3 and actin polymerization.\",\n      \"method\": \"siRNA knockdown, OGD/R model, mitochondrial function assays (ATP, membrane potential, ROS), actin polymerization assay, in vivo cerebral I/R rat model\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — loss-of-function with multiple mechanistic readouts linking SETD3–actin polymerization–mitochondrial function; single lab\",\n      \"pmids\": [\"34218417\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SETD3-deficient female mice show severe reduction in litter sizes due to primary maternal dystocia; depletion of SETD3 impairs signal-induced contraction in primary human uterine smooth muscle cells. Complete loss of actin His73 methylation was confirmed in multiple tissues of SETD3-null mice.\",\n      \"method\": \"SETD3 knockout mice, uterine smooth muscle contraction assays, SETD3 siRNA knockdown in primary human cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — defined phenotype with cellular mechanism (smooth muscle contraction) in KO mice and human primary cells; multiple tissues tested\",\n      \"pmids\": [\"30626964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETD3 interacts with BRD2 in the nucleus of mouse ESCs, and this interaction depends on the RSB domain of SETD3. Loss of SETD3 leads to reduced BRD2 recruitment to chromatin and transcriptional changes; the interaction was confirmed by co-immunoprecipitation, domain deletion analysis, and proximity ligation assays.\",\n      \"method\": \"Mass spectrometry (nuclear pull-down), Co-immunoprecipitation, domain deletion analysis, proximity ligation assay (PLA)\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — reciprocal Co-IP and PLA with domain mapping and functional chromatin consequence; single lab\",\n      \"pmids\": [\"40944926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In mouse ESCs, SETD3 interacts with β-catenin (proximity ligation assay), and loss of SETD3 reduces nuclear β-catenin levels (without changing total protein or mRNA), decreasing canonical Wnt transcriptional activity and causing endoderm differentiation defects that can be rescued by re-expressing SETD3 or activating canonical Wnt signaling.\",\n      \"method\": \"Proximity ligation assay (PLA), time-course RNA-seq, nuclear fractionation, Wnt reporter assay, SETD3 rescue experiments\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — PLA + fractionation + reporter assay + rescue; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"38334393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SETD3 promotes H3K4 methylation at the NLRP3 transcription start site in hippocampal microglia, activating the NLRP3-Caspase-1-IL-1β signaling pathway and enhancing neuroinflammation after surgery.\",\n      \"method\": \"SETD3 knockdown via lentiviral injection, ChIP for H3K4me3 at NLRP3 promoter, neuroinflammation cytokine assays, behavioral tests\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP-level ChIP with knockdown; single lab; histone methylation as direct substrate of SETD3 is disputed by other literature\",\n      \"pmids\": [\"41175962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The Trp79 binding pocket of SETD3 plays an important role in efficient His73 methylation catalysis; substitution of Trp79 in β-actin peptides with less bulky or hydrophilic residues reduces SETD3 catalytic activity, and molecular dynamics simulations show the pocket is shaped to accommodate the large hydrophobic Trp79.\",\n      \"method\": \"In vitro methyltransferase assay (MALDI-TOF MS), molecular dynamics simulations, synthetic peptide substitutions\",\n      \"journal\": \"Chembiochem\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic substrate mutagenesis supported by computational analysis defining a distal binding determinant for SETD3 catalysis\",\n      \"pmids\": [\"37581408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The pathogenic G74S β-actin mutation (associated with BWCFF syndrome) disrupts SETD3-mediated His73 methylation; enzymatic assays confirm slower turnover of mutant actin peptides, and mass spectrometry reveals decreased His73 methylation in recombinant mutant β-actin and patient-derived fibroblasts.\",\n      \"method\": \"Enzymatic turnover assays, mass spectrometry (patient fibroblasts and recombinant protein), molecular docking\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic assays plus mass spectrometry in patient-derived material; single lab\",\n      \"pmids\": [\"40490999\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SETD3 is a dual-localization SET-domain enzyme whose primary established function is as the actin histidine-N3 methyltransferase that methylates β-actin at His73, a modification that reduces nucleotide exchange on monomers, promotes filament assembly, and is required for smooth muscle contractility; SETD3 also methylates MCM7 at His459 to promote replication origin firing, CHD1 at Lys209 to stabilize it and activate NFκB target genes, and α-centractin in vitro; its protein stability is controlled by GSK3β-FBXW7β-mediated ubiquitin-proteasomal degradation and NUDT16-mediated dePARylation; and, independent of its methyltransferase activity, cytosolic SETD3 interacts with enteroviral 2A protease and is essential for enterovirus RNA replication.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SETD3 is a SET-domain methyltransferase whose principal physiological function is the histidine-N3 methylation of \\u03b2-actin at His73, the only detectable physiological substrate identified by quantitative proteomics, a modification that reduces nucleotide exchange on actin monomers and accelerates filament assembly [#0, #1]. Crystal structures of SAH-bound SETD3 with unmodified and methylated \\u03b2-actin peptides define a highly sequence-specific recognition mode in which both enzyme and substrate undergo pronounced conformational changes [#4], and catalysis proceeds through a ~105\\u00b0 rotation of the His73 imidazole ring that shifts a proton from N3 to N1 to deprotonate the target nitrogen prior to methyl transfer [#6]; distal substrate determinants including the actin Trp79 pocket govern catalytic efficiency [#24]. This actin-methylation activity is physiologically required for smooth muscle contractility, with SETD3-null mice showing maternal dystocia and impaired uterine smooth muscle contraction [#20], and disease relevance is underscored by the BWCFF-associated \\u03b2-actin G74S mutation, which impairs His73 methylation in patient-derived fibroblasts and recombinant protein [#25]. Beyond actin, SETD3 methylates additional substrates to control distinct programs: MCM7 at His459 to license replication origin firing [#14], CHD1 at Lys209 to stabilize it and activate TNF-NF\\u03baB target genes [#17], and \\u03b1-centractin in vitro [#18]. In a methyltransferase-independent role, cytosolic SETD3 binds the enteroviral 2A protease and is essential for enterovirus RNA replication and pathogenesis [#3]. SETD3 abundance is tightly regulated by competing post-translational pathways, including GSK3\\u03b2-primed FBXW7\\u03b2-mediated proteasomal degradation [#5] and PARP1/NUDT16-controlled (de)PARylation that gates CHFR-dependent turnover [#16]. SETD3 also localizes to the outer mitochondrial membrane, where mechanosensitive actin methylation supports F-actin organization, complex I assembly, and oxidative phosphorylation [#12].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established the first functional context for SETD3, linking it to muscle gene transcription and differentiation before its true substrate was known.\",\n      \"evidence\": \"Overexpression/knockdown, reporter and ChIP assays in C2C12 myoblasts\",\n      \"pmids\": [\"21832073\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Assigned histone H3K4/H3K36 as substrate, later disputed\", \"Did not identify actin as the physiological target\", \"Mechanism connecting SETD3 to myogenin promoter unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified SETD3 as a PCNA-interacting protein, providing an early hint of a replication-associated role.\",\n      \"evidence\": \"BiFC screen with Co-IP and recombinant protein validation\",\n      \"pmids\": [\"26030842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of PCNA binding not defined\", \"No methylation activity linked to the interaction\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Proposed FoxM1 as a SETD3 substrate regulating VEGF transcription, extending candidate non-histone targets.\",\n      \"evidence\": \"Proteomic screen, Co-IP, methyltransferase and ChIP assays\",\n      \"pmids\": [\"27845446\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Methylation site on FoxM1 not mapped\", \"Distinct from later-established actin substrate\", \"Single lab without orthogonal in vivo confirmation\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Defined how SETD3 protein levels are controlled across the cell cycle, establishing a kinase-coupled degradation circuit.\",\n      \"evidence\": \"Co-IP, phosphodegron mutagenesis, GSK3\\u03b2 inhibition, cell synchronization, xenografts\",\n      \"pmids\": [\"28442573\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect SETD3 stability to a specific enzymatic output\", \"Upstream signals controlling GSK3\\u03b2-dependent phosphorylation unclear\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the central question of SETD3's physiological function by identifying \\u03b2-actin His73 as its sole detectable substrate and defining the structural basis of recognition.\",\n      \"evidence\": \"In vitro methyltransferase assays, X-ray crystallography, quantitative proteomics, KO mice and HAP1/Drosophila knockouts\",\n      \"pmids\": [\"30626964\", \"30526847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not fully resolve catalytic proton-shuttling mechanism\", \"Cellular consequences of His73 methylation only partially mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the catalytic chemistry of histidine N3 methylation through pre- and post-reactive structures and linked the enzyme to a physiological smooth-muscle phenotype.\",\n      \"evidence\": \"Crystallography of reaction intermediates, biochemistry, and KO mice/human uterine smooth muscle contraction assays\",\n      \"pmids\": [\"31388018\", \"30785395\", \"30626964\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why His73 methylation is required for contractility at the molecular level incompletely defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered a methyltransferase-independent function in which SETD3 is hijacked by enteroviruses as an essential host factor for RNA replication.\",\n      \"evidence\": \"Genome-scale CRISPR screens, AP-MS, rescue with interaction-deficient 2A mutants, in vivo mouse infection\",\n      \"pmids\": [\"31527793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular role of SETD3 in the viral replication complex undefined\", \"Structural basis of 2A protease interaction unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Linked SETD3 catalytic activity to p53-dependent apoptosis, expanding its candidate transcriptional roles.\",\n      \"evidence\": \"Co-IP, ChIP, siRNA knockdown, apoptosis assays in HCT-116 cells\",\n      \"pmids\": [\"30683849\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct p53 methylation site not established\", \"Single cell line, single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Mapped the active-site determinants of substrate selectivity, showing histidine versus lysine/methionine targeting is governed by specific pocket residues.\",\n      \"evidence\": \"Crystallography of methionine-containing and engineered variants, kinetics, mutagenesis\",\n      \"pmids\": [\"32503840\", \"31911441\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Engineered specificity switches not observed in cellular substrates\", \"Physiological relevance of weak alternative activities unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Added a stabilizing deubiquitinase to the SETD3 regulatory network, tying its abundance to cancer cell proliferation.\",\n      \"evidence\": \"Co-IP, ubiquitination assays, USP27 knockdown in hepatocellular carcinoma cells\",\n      \"pmids\": [\"35018513\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether USP27 acts directly on SETD3 ubiquitin chains not fully resolved\", \"Link to specific methylation output undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identified MCM7 His459 as a new SETD3 substrate controlling origin licensing and connected CDK2 phosphorylation of SETD3 to S-phase entry.\",\n      \"evidence\": \"NS-seq, Co-IP, H459 mutagenesis, CDK2 phosphorylation assays\",\n      \"pmids\": [\"39455502\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement of MCM7 methylation not tested in animals\", \"Single lab\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed SETD3-mediated actin methylation at the outer mitochondrial membrane as a mechanosensitive regulator of mitochondrial structure and bioenergetics.\",\n      \"evidence\": \"Live-cell imaging, fractionation, loss-of-function with OXPHOS/complex I readouts, ECM stiffness modulation\",\n      \"pmids\": [\"38896010\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"How ECM stiffness is transduced to SETD3 activity unknown\", \"Direct mitochondrial actin substrate pool not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected SETD3 to PARylation-dependent stability control and to a role in BRCA2 recruitment during replication stress and DNA damage.\",\n      \"evidence\": \"Co-IP, PARylation/dePARylation assays, depletion with replication-stress and irradiation-sensitivity readouts\",\n      \"pmids\": [\"38272222\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether SETD3 methylates a DNA-repair substrate unresolved\", \"Mechanism of BRCA2 recruitment undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Implicated SETD3 in splicing regulation through hnRNPK, linking it to TFEB-driven lysosomal and mitochondrial biogenesis.\",\n      \"evidence\": \"Proximity labeling/MS, RNA-seq, Co-IP, loss-of-function on FNIP1 exon skipping\",\n      \"pmids\": [\"39391005\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Catalytic dependence of splicing function not established\", \"Direct RNA contact by SETD3 unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established SETD3 as a regulator of canonical Wnt signaling and endoderm differentiation in ESCs via \\u03b2-catenin.\",\n      \"evidence\": \"PLA, nuclear fractionation, Wnt reporter, time-course RNA-seq, rescue experiments\",\n      \"pmids\": [\"38334393\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether \\u03b2-catenin is methylated not shown\", \"Mechanism stabilizing nuclear \\u03b2-catenin undefined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Expanded the SETD3 substrate/interactor repertoire to CHD1, \\u03b1-centractin, and BRD2, and tied actin methylation to a human \\u03b2-actin disease mutation.\",\n      \"evidence\": \"In vitro methyltransferase and ubiquitination assays, ChIP, TurboID/MS, PLA, domain mapping, enzymatic turnover on patient-derived actin\",\n      \"pmids\": [\"41045985\", \"41142317\", \"40944926\", \"40490999\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cellular validation of several new substrates incomplete\", \"Catalytic versus scaffold contributions to BRD2/centractin interactions unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved which non-actin substrates and interactions are catalytically dependent and physiologically significant, and how SETD3's nuclear, cytosolic, and mitochondrial pools are functionally partitioned.\",\n      \"evidence\": \"No single study reconciles the multiple proposed substrates and localizations\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model of substrate hierarchy beyond \\u03b2-actin\", \"Localization-specific activity regulation undefined\", \"Catalytic requirement of viral and chromatin interactions only partly tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 4, 6, 14, 17, 18]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 14, 17, 18]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [0, 1, 18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14, 21, 22]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 14, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ACTB\", \"MCM7\", \"CHD1\", \"ACTR1A\", \"BRD2\", \"hnRNPK\", \"FBXW7\", \"BRCA2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}